ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment Optimization of Cetuximab in Patients With Metastatic Colorectal Cancer Based on Tumor Uptake of 89Zr-labeled Cetuximab Assessed by PET

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01691391
Recruitment Status : Completed
First Posted : September 24, 2012
Last Update Posted : March 21, 2017
Sponsor:
Information provided by (Responsible Party):
Laura Pijpers, VU University Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2015
  Actual Study Completion Date : July 2016